Analysts recommendations

Astrazeneca: Goldman Sachs’s analyst Keyur Parekh maintains his Sell rating on the stock. The target price continues to be set at GBX 6400.

WPP: Goldman Sachs is positive on the stock with a Buy rating. The target price has been revised upwards and is now set at GBX 920, compared with GBX 810 previously.

Pfizer: Goldman Sachs analyst Terence Flynn maintains his Neutral opinion on the stock. The target price remains set at USD 40.

Unicredit: Jean-Francois Neuez from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is lowered from EUR 12.70 to EUR 10.70.

BASF: Credit Suisse’s analyst Chris Counihan has upgraded his rating from Neutral to Buy. The target price is being increased from EUR 59 to EUR 73.

NOKIA: Credit Suisse’s research confirms his advice and maintains his neutral opinion on the stock. The target price is revised downwards from EUR 3.05 to EUR 2.95.

RWE: JP Morgan analyst Vincent Ayral maintains his Buy rating on the stock. The target price remains set at EUR 38.

BHP Group: In his latest research note, analyst Dominic O’Kane confirms his positive recommendation. The broker JP Morgan is keeping its Buy rating. Previously set at GBX 2210, the target price has been raised to GBX 2390.

Rio Tinto: Dominic O’Kane from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price has been lifted and is now set at GBX 7130 compared to GBX 6230 before.

Goldman Sachs: Goldman Sachs (GS) has an average outperform rating among analysts with a price target range of $200 to $366.